$7.80
-0.59-7.03%
At Close: -
$7.62
-0.18-2.31%
After Hours: Jul 11, 8:50 AM EDT
15 minutes delayed
Comments
Loading...
Singular Genomics Sys (NASDAQ:OMIC) Stock, Analyst Ratings, Price Targets, Forecasts
Singular Genomics Systems Inc has a consensus price target of $3.33 based on the ratings of 3 analysts. The high is $6.5 issued by Goldman Sachs on July 9, 2024. The low is $0.5 issued by UBS on March 20, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, Goldman Sachs, and UBS on July 9, 2024, May 15, 2024, and March 20, 2024, respectively. With an average price target of $2.58 between Goldman Sachs, Goldman Sachs, and UBS, there's an implied -66.10% downside for Singular Genomics Systems Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
UBS
B of A Securities
1calculated from analyst ratings
Analyst Ratings for Singular Genomics Sys
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | Buy Now | -14.7% | Goldman Sachs | Matthew Sykes | $22.5 → $6.5 | Maintains | Neutral | Get Alert |
| 05/15/2024 | Buy Now | -90.16% | Goldman Sachs | Matthew Sykes | $25.5 → $22.5 | Maintains | Neutral | Get Alert |
| 03/20/2024 | Buy Now | -93.44% | UBS | John Sourbeer | $12 → $15 | Maintains | Neutral | Get Alert |
| 01/23/2024 | Buy Now | -88.85% | Goldman Sachs | Matthew Sykes | $28.5 → $25.5 | Maintains | Neutral | Get Alert |
| 01/22/2024 | Buy Now | -88.85% | Goldman Sachs | Matthew Sykes | $28.5 → $25.5 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | -86.88% | Goldman Sachs | Matthew Sykes | $34.5 → $30 | Maintains | Neutral | Get Alert |
| 11/08/2022 | Buy Now | -60.63% | Goldman Sachs | Matthew Sykes | $105 → $90 | Maintains | Neutral | Get Alert |
| 08/17/2022 | Buy Now | -40.94% | UBS | John Sourbeer | $300 → $135 | Downgrade | Buy → Neutral | Get Alert |
| 08/10/2022 | Buy Now | -60.63% | B of A Securities | Michael Ryskin | → $90 | Downgrade | Buy → Underperform | Get Alert |
| 08/10/2022 | Buy Now | -54.07% | Goldman Sachs | Matthew Sykes | → $105 | Downgrade | Buy → Neutral | Get Alert |
| 07/14/2022 | Buy Now | -34.38% | Goldman Sachs | Matthew Sykes | $285 → $150 | Maintains | Buy | Get Alert |
| 05/11/2022 | Buy Now | 24.67% | Goldman Sachs | Matthew Sykes | $330 → $285 | Maintains | Buy | Get Alert |
| 04/13/2022 | Buy Now | 44.36% | Goldman Sachs | Matthew Sykes | $510 → $330 | Maintains | Buy | Get Alert |
| 01/07/2022 | Buy Now | 175.59% | B of A Securities | Michael Ryskin | → $630 | Upgrade | Neutral → Buy | Get Alert |
FAQ
What is the target price for Singular Genomics Sys (OMIC) stock?
The latest price target for Singular Genomics Sys (NASDAQ:OMIC) was reported by Goldman Sachs on July 9, 2024. The analyst firm set a price target for $6.50 expecting OMIC to fall to within 12 months (a possible -14.70% downside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Singular Genomics Sys (OMIC)?
The latest analyst rating for Singular Genomics Sys (NASDAQ:OMIC) was provided by Goldman Sachs, and Singular Genomics Sys maintained their neutral rating.
When was the last upgrade for Singular Genomics Sys (OMIC)?
The last upgrade for Singular Genomics Systems Inc happened on January 7, 2022 when B of A Securities raised their price target to $21. B of A Securities previously had a neutral for Singular Genomics Systems Inc.
When was the last downgrade for Singular Genomics Sys (OMIC)?
The last downgrade for Singular Genomics Systems Inc happened on August 17, 2022 when UBS changed their price target from $10 to $4.5 for Singular Genomics Systems Inc.
When is the next analyst rating going to be posted or updated for Singular Genomics Sys (OMIC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Singular Genomics Sys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Singular Genomics Sys was filed on July 9, 2024 so you should expect the next rating to be made available sometime around July 9, 2025.
Is the Analyst Rating Singular Genomics Sys (OMIC) correct?
While ratings are subjective and will change, the latest Singular Genomics Sys (OMIC) rating was a maintained with a price target of $22.50 to $6.50. The current price Singular Genomics Sys (OMIC) is trading at is $7.62, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.